Shopping Cart 0
Cart Subtotal
AED 0

Monash University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Monash University is an educational service provider that offers undergraduate and postgraduate coursework programs. The university offers programs in diverse areas of business, communications and media, design, creative art, architecture, education engineering, medicine, nursing and health sciences, environment and sustainability, humanities and cultures, and others. It also offers off-campus courses with academic assistance and required materials. Monash University undertakes research in various fields of study such as biological and biotechnological sciences, medical and health sciences, engineering and environmental sciences, humanities and creative arts, mathematical, and others. The university has presence in Australia, South Africa, Malaysia, Italy, India and China. Monash is headquartered in Clayton, Victoria, Australia.

Monash University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Monash University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Monash University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Monash University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Monash University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Monash University, Medical Devices Deals, 2012 to YTD 2018 10

Monash University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Monash University, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

Johnson & Johnson Innovation and Janssen Biotech Enter into Partnership with Monash University 13

Monash University Enters into Research Agreement with Janssen Biotech 14

Cynata Therapeutics Enters into Agreement with Monash Lung Biology Network 15

Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 16

Gordagen Pharma Enters into Research Agreement with Monash University 18

Monash Institute and Monash University Enter into Research Agreement with Takeda Pharma 19

60P Australia Partners with Monash University 20

GlaxoSmithKline, Monash University, McCall MacBain Foundation, Grand Challenges Canada and Planet Wheeler Foundation Enter into Co-Development Agreement 21

Immuron Enters Into Co-Development Agreement With Monash University 22

Les Labs Servier Enters Into Research Agreement With Monash Institute 23

Licensing Agreements 24

Corvus Pharma Enters into Licensing Agreement with Monash University 24

Asset Transactions 25

Aravax Acquires Intellectual Property Rights from Alfred Health Victoria and Monash University 25

Capsugel Acquires Ionic Liquids Technology from Monash University 26

Monash University-Key Competitors 27

Monash University-Key Employees 28

Monash University-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 31

Strategy And Business Planning 31

Jul 26, 2018: Australia's first dedicated blood cancer therapeutics centre launched 31

Government and Public Interest 32

Sep 11, 2018: USD 10 million for six new clinical trials 32

Feb 23, 2018: Molecular link uncovered between Vitamin A and intestinal health 35

Jan 24, 2018: USD 69 million boost for fight against rare cancers and rare diseases 36

Dec 08, 2017: GBP3.9m project to support elimination of the world's leading infectious cause of blindness 39

Oct 27, 2017: 3D 'scaffold' map to help the search for new cancer treatments 41

Sep 20, 2017: Rethink on beta blockers for heart attack survivors who take their other heart medication 43

Aug 30, 2017: Prima Biomed And Monash University Receive Funding Grant For Lag-3 Research Project 44

Jul 18, 2017: Antibiotic insight may help in battle against bacterial resistance 45

May 03, 2017: New Pathway For Blood Cancer Therapies 46

Mar 01, 2017: Combination of ground-breaking treatments offer powerful new path for blood cancer therapies 47

Product News 48

Aug 16, 2017: Monash helps address superbug resistance with Phage therapy 48

May 31, 2017: Monash University researchers develop game changing strategy for pain relief 49

Other Significant Developments 50

Sep 16, 2018: Daily low-dose aspirin found to have no effect on healthy life span in older people 50

Aug 01, 2018: Stem cell research to tackle blindness and congenital heart disease in kids 52

Appendix 54

Methodology 54

About GlobalData 54

Contact Us 54

Disclaimer 54


List Of Figure

List of Figures

Monash University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Monash University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Monash University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Monash University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Monash University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Monash University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Monash University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Monash University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Monash University, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Monash University, Pharmaceuticals & Healthcare, Key Facts 2

Monash University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Monash University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Monash University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Monash University, Deals By Therapy Area, 2012 to YTD 2018 9

Monash University, Medical Devices Deals, 2012 to YTD 2018 10

Monash University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Johnson & Johnson Innovation and Janssen Biotech Enter into Partnership with Monash University 13

Monash University Enters into Research Agreement with Janssen Biotech 14

Cynata Therapeutics Enters into Agreement with Monash Lung Biology Network 15

Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 16

Gordagen Pharma Enters into Research Agreement with Monash University 18

Monash Institute and Monash University Enter into Research Agreement with Takeda Pharma 19

60P Australia Partners with Monash University 20

GlaxoSmithKline, Monash University, McCall MacBain Foundation, Grand Challenges Canada and Planet Wheeler Foundation Enter into Co-Development Agreement 21

Immuron Enters Into Co-Development Agreement With Monash University 22

Les Labs Servier Enters Into Research Agreement With Monash Institute 23

Corvus Pharma Enters into Licensing Agreement with Monash University 24

Aravax Acquires Intellectual Property Rights from Alfred Health Victoria and Monash University 25

Capsugel Acquires Ionic Liquids Technology from Monash University 26

Monash University, Key Competitors 27

Monash University, Key Employees 28

Monash University, Other Locations 29

Monash University, Subsidiaries 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Monash University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Monash University is an educational service provider that offers undergraduate and postgraduate coursework programs. The university offers programs in diverse areas of business, communications and media, design, creative art, architecture, education engineering, medicine, nursing and health sciences, environment and sustainability, humanities and cultures, and others. It also offers off-campus courses with academic assistance and required materials. Monash University undertakes research in various fields of study such as biological and biotechnological sciences, medical and health sciences, engineering and environmental sciences, humanities and creative arts, mathematical, and others. The university has presence in Australia, South Africa, Malaysia, Italy, India and China. Monash is headquartered in Clayton, Victoria, Australia.

Monash University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Monash University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Monash University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Monash University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Monash University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Monash University, Medical Devices Deals, 2012 to YTD 2018 10

Monash University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Monash University, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

Johnson & Johnson Innovation and Janssen Biotech Enter into Partnership with Monash University 13

Monash University Enters into Research Agreement with Janssen Biotech 14

Cynata Therapeutics Enters into Agreement with Monash Lung Biology Network 15

Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 16

Gordagen Pharma Enters into Research Agreement with Monash University 18

Monash Institute and Monash University Enter into Research Agreement with Takeda Pharma 19

60P Australia Partners with Monash University 20

GlaxoSmithKline, Monash University, McCall MacBain Foundation, Grand Challenges Canada and Planet Wheeler Foundation Enter into Co-Development Agreement 21

Immuron Enters Into Co-Development Agreement With Monash University 22

Les Labs Servier Enters Into Research Agreement With Monash Institute 23

Licensing Agreements 24

Corvus Pharma Enters into Licensing Agreement with Monash University 24

Asset Transactions 25

Aravax Acquires Intellectual Property Rights from Alfred Health Victoria and Monash University 25

Capsugel Acquires Ionic Liquids Technology from Monash University 26

Monash University-Key Competitors 27

Monash University-Key Employees 28

Monash University-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 31

Strategy And Business Planning 31

Jul 26, 2018: Australia's first dedicated blood cancer therapeutics centre launched 31

Government and Public Interest 32

Sep 11, 2018: USD 10 million for six new clinical trials 32

Feb 23, 2018: Molecular link uncovered between Vitamin A and intestinal health 35

Jan 24, 2018: USD 69 million boost for fight against rare cancers and rare diseases 36

Dec 08, 2017: GBP3.9m project to support elimination of the world's leading infectious cause of blindness 39

Oct 27, 2017: 3D 'scaffold' map to help the search for new cancer treatments 41

Sep 20, 2017: Rethink on beta blockers for heart attack survivors who take their other heart medication 43

Aug 30, 2017: Prima Biomed And Monash University Receive Funding Grant For Lag-3 Research Project 44

Jul 18, 2017: Antibiotic insight may help in battle against bacterial resistance 45

May 03, 2017: New Pathway For Blood Cancer Therapies 46

Mar 01, 2017: Combination of ground-breaking treatments offer powerful new path for blood cancer therapies 47

Product News 48

Aug 16, 2017: Monash helps address superbug resistance with Phage therapy 48

May 31, 2017: Monash University researchers develop game changing strategy for pain relief 49

Other Significant Developments 50

Sep 16, 2018: Daily low-dose aspirin found to have no effect on healthy life span in older people 50

Aug 01, 2018: Stem cell research to tackle blindness and congenital heart disease in kids 52

Appendix 54

Methodology 54

About GlobalData 54

Contact Us 54

Disclaimer 54


List Of Figure

List of Figures

Monash University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Monash University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Monash University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Monash University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Monash University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Monash University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Monash University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Monash University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Monash University, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Monash University, Pharmaceuticals & Healthcare, Key Facts 2

Monash University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Monash University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Monash University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Monash University, Deals By Therapy Area, 2012 to YTD 2018 9

Monash University, Medical Devices Deals, 2012 to YTD 2018 10

Monash University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Johnson & Johnson Innovation and Janssen Biotech Enter into Partnership with Monash University 13

Monash University Enters into Research Agreement with Janssen Biotech 14

Cynata Therapeutics Enters into Agreement with Monash Lung Biology Network 15

Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 16

Gordagen Pharma Enters into Research Agreement with Monash University 18

Monash Institute and Monash University Enter into Research Agreement with Takeda Pharma 19

60P Australia Partners with Monash University 20

GlaxoSmithKline, Monash University, McCall MacBain Foundation, Grand Challenges Canada and Planet Wheeler Foundation Enter into Co-Development Agreement 21

Immuron Enters Into Co-Development Agreement With Monash University 22

Les Labs Servier Enters Into Research Agreement With Monash Institute 23

Corvus Pharma Enters into Licensing Agreement with Monash University 24

Aravax Acquires Intellectual Property Rights from Alfred Health Victoria and Monash University 25

Capsugel Acquires Ionic Liquids Technology from Monash University 26

Monash University, Key Competitors 27

Monash University, Key Employees 28

Monash University, Other Locations 29

Monash University, Subsidiaries 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Monash University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.